/PRNewswire/ -- Actavis plc (NYSE: ACT) is proud to participate in today's White House Forum on Antibiotic Stewardship, which assembles key Federal... ...http://in.advfn.com/p.php?pid=nmona&article=67112026
The article below represents a preview only and is not meant for reuse or republishing. Health & Lifestyle RTT News Online News India, June 2... ...http://www.htsyndication.com/htsportal/article/Novartis-To-Present-New-Data-On-Secukinumab---Quick-Facts/7259926
PINE BROOK, N.J. , June 1, 2015 /PRNewswire/ --Elusys Therapeutics, Inc. (Elusys) today announced the U.S. Food and Drug Administration (FDA) has... ...http://www.asianhhm.com/pressreleases/u-s-food-and-drug-administration-accepts-biologics-license-application-for-anthim-obiltoxaximab
/PRNewswire/ --Amgen (NASDAQ: AMGN) today announced results from a randomized, double-blind, placebo-controlled, multicenter Phase 3 study... ...http://in.advfn.com/p.php?pid=nmona&article=67096044
By: Nasrin Modak-Siddiqi Genetic labs and fitness centres collaborate to offer you a weight loss trick based on your genes. Should we bite the... ...http://www.bangaloremirror.com/columns/you/weight-loss-genetic-labs-fitness-centres/articleshow/47360835.cms
Read the best and honest review on...